Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study

Clinical Infectious Diseases(2021)10.1093/cid/ciab072Source: DataRank Database

Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study is a research paper published in Clinical Infectious Diseases (2021). On theSindex it has a DataRank of 0. It has been cited 140 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access140 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (19 grants)Impact (FWCI 11.95)OA: bronzeTopics (41)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (33)

William Bain ORCID,Jana L. Jacobs ORCID,Sham Nambulli ORCID,Urvi M. Parikh ORCID,Anthony R. Cillo ORCID

Live enrichment

PubMed:33507235 PMC:PMC7929077 OpenAlex:https://openalex.org/W3121193681

National Institutes of Health

Grant: KL2TR001856

U.S. Department of Veterans Affairs

Grant: IK2 BX004886

U.S. Department of Veterans Affairs

Grant: P50 8 P50 AI150464

University of Pittsburgh

Grant: P01HL114453

University of Pittsburgh

Grant: R01 HL136143

NHLBI NIH HHS

Grant: R01 HL142084

NIAID NIH HHS

Grant: P01 AI108545

NIAID NIH HHS

Grant: P50 AI150464

NCI NIH HHS

Grant: P50 CA097190

NHLBI NIH HHS

Grant: K24 HL143285

National Institutes of Health

Grant: 5P01HL114453-08

Immunosuppression in Acute Lung Injury

National Institutes of Health

Grant: 3P50AI150464-14S1

Center for the Structural Biology of Cellular Host Elements in Egress, Trafficking, and Assembly of HIV (CHEETAH Center)

National Institutes of Health

Grant: 5R01HL136143-03

Mechanisms of host protection against pathogen-secreted proteases in acute lung injury

National Institutes of Health

Grant: 5P01AI108545-08

Synergies among inhibitory receptors in tolerance, cancer & antiviral immunity

National Institutes of Health

Grant: 5R01CA203689-09

Interleukin-35 and the tumor microenvironment

National Institutes of Health

Grant: 5P50CA097190-10

Administrative Core

National Institutes of Health

Grant: 3KL2TR001856-08S1

Institutional Career Development Core

National Center for Advancing Translational Sciences

University of Pittsburgh Medical Center

FWCI

11.95

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

bronzeLicense: OUP Standard Publication Reuse

journalhttps://academic.oup.com/cid/article-pdf/73/3/e815/39508524/ciab072.pdf

publisherhttps://academic.oup.com/cid/article-pdf/73/3/e815/39508524/ciab072.pdf

publisherhttp://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciab072/36409747/ciab072.pdf

journalhttps://doi.org/10.1093/cid/ciab072

repositoryhttps://pubmed.ncbi.nlm.nih.gov/33507235

Fields of Study

CAR-T cell therapy researchSARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testing0301 basic medicine0303 health sciences03 medical and health sciences

MeSH Terms

Receptors, Chimeric AntigenCOVID-19SARS-CoV-2HumansVirus ReplicationCell- and Tissue-Based Therapy

Keywords

MedicineVirologyCoronavirusVirusImmunologyViral replicationRespiratory diseaseCoronavirus disease 2019 (COVID-19)DiseaseInfectious disease (medical specialty)LungPathologyInternal medicineCovid-19Severe Acute Respiratory Syndrome Coronavirus 2Sars-cov-2 InfectivitySars-cov-2 RnaemiaSars-cov-2 Immune ResponsesSars-cov-2 Intrahost VariationMicrobiology (medical)Receptors, Chimeric AntigenSARS-CoV-2Cell- and Tissue-Based Therapy610Virus ReplicationCOVID-19, SARS-CoV-2 immune responses, SARS-CoV-2 RNAemia, SARS-CoV-2 intrahost variation, SARS-CoV-2 infectivity, severe acute respiratory syndrome coronavirus 2Infectious DiseasesHumansOnline Only Articles

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being